Small Molecule Inhibitors of Stat3 Protein as Cancer Therapeutic Agents
Advances in anti-cancer drug development have vastly improved cancer treatment strategies over the past few decades. Chemotherapeutic agents are now being replaced with targeted therapies that have much greater potency and far fewer unpleasant side effects. At the center of this, cell signaling path...
Main Author: | |
---|---|
Other Authors: | |
Language: | en_ca |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/65451 |